glp 1 nhs England moves to restrict use of GLP-1 agonists MHRA-publishes-updated-GLP-1-guidance-due-to-NAION-risk

I hope that the changing landscape will decrease cost, increase production and improve access to these medications. Patents for semaglutide are now expiring in several countries, paving the way for cheaper generics

Clinical trials showed that the medications were both safe and effective and helped people lose significant percentages of their body weight

So luckily they went in

Pages 581-650 (October 2025) Editorial PRO/CON DOI: 10.1016/j.arbres.2025.03.009 Visits 1963 Download PDF Olga Medianoa,b,c,d,1, Corresponding author [email protected] Corresponding author

Acknowledgment: We acknowledge and appreciate our patient for providing permission to publish this case report

External resources Understanding the full landscape of weight loss medication options is the first step toward making a decision you will not regret